Pages that link to "Q46624831"
Jump to navigation
Jump to search
The following pages link to Hepcidin is decreased in TFR2 hemochromatosis (Q46624831):
Displaying 50 items.
- Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis (Q21129271) (← links)
- STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation (Q24301291) (← links)
- CD81 promotes both the degradation of transferrin receptor 2 (TfR2) and the Tfr2-mediated maintenance of hepcidin expression (Q24317017) (← links)
- A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis (Q24318821) (← links)
- A mouse model of juvenile hemochromatosis (Q24532268) (← links)
- Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6 (Q24550935) (← links)
- Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin (Q24632978) (← links)
- Hereditary hemochromatosis in the post-HFE era (Q24646056) (← links)
- Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis (Q24646911) (← links)
- Pathophysiology of hereditary hemochromatosis (Q24654441) (← links)
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance (Q24682390) (← links)
- Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes (Q24810582) (← links)
- Mechanistic and regulatory aspects of intestinal iron absorption (Q26861531) (← links)
- Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches (Q27027657) (← links)
- Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C (Q27478403) (← links)
- Molecular basis of HFE-hemochromatosis (Q27687811) (← links)
- Hepcidin and iron regulation, 10 years later (Q27690828) (← links)
- Molecular biology, genetics and biochemistry of the repulsive guidance molecule family (Q28255922) (← links)
- Iron imports. I. Intestinal iron absorption and its regulation (Q28272089) (← links)
- Lack of the bone morphogenetic protein BMP6 induces massive iron overload (Q28510138) (← links)
- Localization of the iron-regulatory proteins hemojuvelin and transferrin receptor 2 to the basolateral membrane domain of hepatocytes (Q28581235) (← links)
- Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness (Q28588325) (← links)
- Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry (Q30845135) (← links)
- Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse (Q33303254) (← links)
- A novel immunological assay for hepcidin quantification in human serum (Q33411750) (← links)
- HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients (Q33471093) (← links)
- Hepcidin and sports anemia (Q33559763) (← links)
- Ferroportin1 is required for normal iron cycling in zebrafish (Q33774889) (← links)
- Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice (Q33806074) (← links)
- Hepcidin: A novel peptide hormone regulating iron metabolism (Q33824412) (← links)
- Regulation of hepcidin transcription by interleukin-1 and interleukin-6. (Q33836338) (← links)
- Mass spectrometry analysis of hepcidin peptides in experimental mouse models (Q33847518) (← links)
- Anticancer activity of the iron facilitator LS081 (Q33858923) (← links)
- The molecular basis of ferroportin-linked hemochromatosis (Q33863312) (← links)
- Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis (Q33894300) (← links)
- Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. (Q33999246) (← links)
- Hepcidin in beta-thalassemia (Q34076870) (← links)
- Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. (Q34197725) (← links)
- Hepcidin expression in iron overload diseases is variably modulated by circulating factors (Q34269113) (← links)
- Non-HFE hemochromatosis (Q34304892) (← links)
- Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease (Q34336869) (← links)
- Gender-related variations in iron metabolism and liver diseases (Q34391646) (← links)
- Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. (Q34448824) (← links)
- New insights into the regulation of iron homeostasis (Q34516972) (← links)
- Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin (Q34541753) (← links)
- Hepcidin--central regulator of iron metabolism (Q34571768) (← links)
- Of mice and men: the iron age. (Q34650865) (← links)
- Iron Imports. V. Transport of iron through the intestinal epithelium (Q34651772) (← links)
- Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosis. (Q34655528) (← links)
- Non-HFE haemochromatosis (Q34668872) (← links)